Ampio Announces Update on the Optina™ Clinical Trial, Decision to Conclude the Study Ahead of Schedule

Product News   Mar 20, 2012

 
Ampio Announces Update on the Optina™ Clinical Trial, Decision to Conclude the Study Ahead of Schedule
 
 
FURTHER INFORMATION
 
 
 

Related Product News

TriNetX Unveils Natural Language Processing Service

Product News

Combines EMR and NLP data to deliver the industry’s most comprehensive data set for cohort analysis and site selection.

READ MORE

Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy

Product News

QXDx BCR-ABL %IS Kit Achieves Highest Sensitivity for Detecting Disease Remission in Patients with Chronic Myeloid Leukemia.

READ MORE

QIAGEN Advances Precision Medicine

Product News

First bioinformatics solution integrating new AMP/ASCO/CAP standards for NGS cancer testing to confidently and quickly report clinical relevance of somatic mutations.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE